Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.11 USD | -6.33% |
|
-11.77% | -28.18% |
Sales 2024 * | 219M 17.29B | Sales 2025 * | 225M 17.77B | Capitalization | 150M 11.84B |
---|---|---|---|---|---|
Net income 2024 * | 10M 790M | Net income 2025 * | 15M 1.18B | EV / Sales 2024 * | 0.69 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.67 x |
P/E ratio 2024 * |
12.9
x | P/E ratio 2025 * |
12.8
x | Employees | 185 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.6% |
Latest transcript on Puma Biotechnology, Inc.
1 day | -6.33% | ||
1 week | -11.77% | ||
Current month | -19.22% | ||
1 month | -29.48% | ||
3 months | -37.80% | ||
6 months | -20.66% | ||
Current year | -28.18% |
![Extreme 3.09](/images/extremecours_fleche.png)
![Extreme 3.09](/images/extremecours_fleche.png)
![Extreme 3.09](/images/extremecours_fleche.png)
![Extreme 2.13](/images/extremecours_fleche.png)
![Extreme 1.6](/images/extremecours_fleche.png)
![Extreme 1.6](/images/extremecours_fleche.png)
![Extreme 1.6](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Alan Auerbach
CEO | Chief Executive Officer | 54 | 14/09/10 |
Maximo Nougues
DFI | Director of Finance/CFO | 55 | 04/11/18 |
Alvin Wong
CTO | Chief Tech/Sci/R&D Officer | 71 | 28/02/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 22/02/18 |
Jay Moyes
BRD | Director/Board Member | 70 | 26/04/12 |
Alan Auerbach
CEO | Chief Executive Officer | 54 | 14/09/10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
14/06/24 | 3.11 | -6.33% | 214,217 |
13/06/24 | 3.32 | -7.65% | 570,138 |
12/06/24 | 3.595 | +3.60% | 445,812 |
11/06/24 | 3.47 | -0.57% | 230,465 |
10/06/24 | 3.49 | -0.99% | 179,163 |
Delayed Quote Nasdaq, June 14, 2024 at 09:00 pm
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.18% | 150M | |
+40.80% | 53.67B | |
+34.58% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- PBYI Stock